Nikola Glišić scouting report: a 19-goal full-back — the real price of the attacking profile

Nikola Glišić scouting report: a 19-goal full-back — the real price of the attacking profile
Yazı Özetini Göster

Nikola Glišić
Right-Back
MevkiRight-Back
KulüpFK IMT
UyrukSerbia
Yaş27
Doğum30.06.1999
Boy1.75 m
AyakRight
Piyasa Değeri€800K
Sözleşme10.01.2027
RolAttacking Full-Back / Winger Alternative

67/100
GP SCOREAn attacking full-back with 19 career goals and a steady 25-game season; failing to stick at Zvezda leaves the level-ceiling question open.

Overview

Nikola Glišić, born 30 June 1999 in Belgrade, broke out at IMT, joined the Second League title run, moved to Crvena Zvezda in 2022 — but found no minutes and returned to IMT, on loan in 2023-24 and permanently in February 2024.

2025-26: 25 league games, 2 goals, 1 assist, a 6.7 average. Career: ~19 goals in ~107 league games — an exceptional rate for a full-back. Right-wing and left-back alternatives.

The open question: was the Zvezda failure a level ceiling or timing? At 27 a second big-club window is narrow, but the output profile stays interesting for mid budgets.

Career and Data

2025-26
İstatistikDeğerPersentil
League apps25
Goals2
Assists1
Rating6.767
Career goals (FB)19
Soccerway/Sofascore.
Strengths Development Areas
Exceptional full-back goal output (19 in ~107) The failed Zvezda trial — a ceiling question
Three-position flexibility 1.75 m — aerial ceiling
A January 2027 contract — price pressure nearing Never on the national-team radar

Verdict

GP VERDICTWATCH

A productive full-back profile plus a contract narrowing in January 2027 opens a low-fee window; the ceiling question needs live scouting.

If output holds through autumn 2026-27, a winter move in the €500-800K band is rational.

FAQ

Who is Nikola Glišić?

A right-back born 30 June 1999 in Belgrade; an IMT breakout who returned permanently in 2024 after a Zvezda spell.


When does his contract expire?

10 January 2027.

GEGEN SCORE blends technical (20%), tactical (20%), mental (20%), physical (15%), potential (15%) and risk (10%, inverse-weighted) components into one editorial rating; it is a comparison tool, not a transfer decision by itself. Bio data verified against independent open sources. Last updated: 27 July 2026.

Bir Yorum Yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

Benzer Yazılar